Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From PowerVision, Inc.
With the eye-care business set for its own stock exchange listings next month and the future of Sandoz the subject of much discussion, Novartis' plan to be a pure play pharma firm moves ever closer.
Liquid biopsy developer Laboratory for Advanced Medicine (LAM) named Jinjie Hu as chief regulatory officer.
Whether used for training surgeons outside of the operating room or as a valuable reference tool during surgery, the recent AAOS annual conference shows that orthopedic surgeons rank among several pioneering clinician groups who are embracing surgical solutions that extend into the worlds of virtual, augmented, and mixed reality. With the global shift toward value-based health care, Proponents say these new technologies may offer surgeons new ways to improve operating times and efficiency, better patient outcomes and cut overall costs.
The arrival of a new generation of intraocular lenses and corneal inlays – designed to offer clearer, improved vision without the need for reading glasses – is expected to spur growth in the presbyopia market.
- Implantable Devices
- Surgical Equipment & Devices
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.